phase3

1 stories · following the connections

Business

Abeona Therapeutics Receives Guidance from FDA to Commence Pivotal Phase 3 for EB-101 Gene Therapy for Patients with Epidermolysis Bullosa

By Nasdaq OMXJul 18, 2017, 12:05 PM UTC